Khanh Cong Nguyen - Concepedia

Author

Khanh Cong Nguyen

Also Known As

Cong-Khanh Nguyen, Hien T. Nguyen, Huyen T. Nguyen, K. Nguyen, K.C. Nguyen, Khanh Cong Nguyen, Khanh C. Nguyen, Khanh Cong Nguyen, Khanh Cong Nguyen, MD, MSc, Khanh Nguyen

Publications

2.2K

Citations

H-Index

101

Concepts

All Affiliations

Stanford University National Institute Of Hygiene And Epidemiology Ministry of Health Australian National University General Department of Preventive Medicine

About

Khanh Cong Nguyen is an author at Stanford University specializing in medicine, covid-19, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.6K
2	Public Health	5	5	330
3	Engineering	3	3	56
4	Health Sciences	1	1	10
5	Natural Sciences	1	1	66

Khanh Cong Nguyen

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Progenitor identification and SARS-CoV-2 infection in human distal lung organoids Ameen A. Salahudeen, S. S. Choi, Arjun Rustagi, Nature Respiratory DiseasesProgenitor IdentificationPathologyVirologyRespiratory Infection	2020	406
Structure of the neurotensin receptor 1 in complex with β-arrestin 1 Weijiao Huang, Matthieu Masureel, Qianhui Qu, Nature Molecular PharmacologyNeuropeptidesMolecular NeuroscienceMolecular PhysiologyG Protein-coupled Receptor	2020	388
Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity Jacqueline A. Carozza, Volker Böhnert, Khanh Cong Nguyen, Nature Cancer Radiation-induced Anticancer ImmunityCancer ImmunosurveillanceMalignant DiseaseCancer-cell-produced ImmunotransmitterImmunology	2020	317
Transmission of SARS-CoV 2 During Long-Haul Flight Khanh Cong Nguyen, Phạm Quang Thái, Ha‐Linh Quach, Emerging infectious diseases In-flight TransmissionVirus EpidemiologyCovid-19 Epidemiology10-Hour Commercial FlightCovid-19	2020	216
The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam Phạm Quang Thái, Maia A. Rabaa, Duong Huy Luong, Clinical Infectious Diseases	2020	78
Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ Florentine U. Rutaganira, M.L. Fowler, Jacob A. McPhail, Journal of Medicinal Chemistry Structural CharacterizationDrug TargetSynthetic VirologyEssential EnzymeMolecular Biology	2016	66
PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma Xiaochao Tan, Priyam Banerjee, Edward A. Pham, Science Translational Medicine	2020	63
Emerging COVID-19 success story: Vietnam’s commitment to containment Todd Pollack, Louise Thwaites, Maia A. Rabaa, Covid-19 Success StoryEmerging Infectious DiseasesGlobal HealthGlobal Health CrisisCovid-19 Pandemic	2020	60
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2 Rachel J. Hagey, Menashe Elazar, Edward A. Pham, Nature Medicine Virus StructureViral ReplicationSynthetic VirologyAntiviral Drug DevelopmentMolecular Biology	2022	49
Phosphatidylinositol 4,5-Bisphosphate Is an HCV NS5A Ligand and Mediates Replication of the Viral Genome Nam‐Joon Cho, Choongho Lee, Phillip S. Pang, Gastroenterology Viral ReplicationMolecular VirologyHcv Ns5a LigandNeurovirologyPhosphatidylinositol 4,5-Bisphosphate	2014	42

Page 1